文献速递创伤与烧伤重症综合管理与镇静镇痛

成人重型创伤性脑损伤早期与晚期启动化学性静脉血栓栓塞预防:系统评价与Meta分析

Early Versus Late Initiation of Chemical Venous Thromboembolism Prophylaxis in Adult Patients with Severe Traumatic Brain Injury: A Systematic Review and Meta-analysis.
PubMed 文献 · Neurocrit Care · 2025-11-14
一句话结论重型TBI患者早期启动化学性VTE预防与VTE风险降低相关(OR 0.47),≤48小时启动还伴死亡率降低(OR 0.74),但证据受异质性和偏倚风险限制。

该系统评价与Meta分析检索5个数据库至2024年10月,纳入21项研究(其中14项、n=24,401进入Meta分析),比较重型TBI(GCS≤8或AIS≥3)早期与晚期启动化学性VTE预防。早期启动与VTE风险降低相关(OR 0.47;95%CI 0.37-0.60),≤48小时(OR 0.39)和≤72小时(OR 0.52)分层一致,≤24小时分层未达统计学显著(OR 0.48;95%CI 0.14-1.60)。未见出血进展、神经外科干预或死亡率显著增加,≤48小时启动者死亡率显著更低(OR 0.74;95%CI 0.63-0.87)。所有纳入研究偏倚风险为中至重度,作者认为结果支持更早启动化学性VTE预防,但需谨慎解读并需高质量前瞻性研究。

要点

  • 重型TBI(GCS≤8或AIS≥3)早期启动化学性VTE预防与VTE风险降低相关:OR 0.47(95%CI 0.37-0.60)。
  • ≤48小时启动分层VTE风险降低(OR 0.39;95%CI 0.23-0.65),≤72小时启动亦降低(OR 0.52;95%CI 0.39-0.69)。
  • ≤24小时启动分层VTE风险未达统计学显著(OR 0.48;95%CI 0.14-1.60)。
  • ≤48小时启动化学性VTE预防者死亡率显著更低:OR 0.74(95%CI 0.63-0.87)。
  • 未见出血进展、神经外科干预或死亡率显著增加,但所有纳入研究偏倚风险为中至重度。

适用人群与场景

  • 成人重型创伤性脑损伤患者,重型定义为格拉斯哥昏迷评分≤8分或简明损伤定级标准评分≥3分。

诊断标准与关键阈值

  • 重型TBI定义:格拉斯哥昏迷评分≤8分或简明损伤定级标准评分≥3分。
  • 分层阈值:早期与晚期启动化学性VTE预防的切点分别为≤24小时、≤48小时和≤72小时。

研究设计与关键结果

  • 研究类型:系统评价与Meta分析,检索5个数据库(建库至2024年10月),纳入21项研究,其中14项(n=24,401)进入Meta分析,采用随机效应模型合并,计算比值比(OR)。
  • 早期与晚期启动化学性VTE预防比较:VTE风险降低(OR 0.47;95%CI 0.37-0.60)。
  • 分层分析:≤48小时启动VTE风险降低(OR 0.39;95%CI 0.23-0.65),≤72小时启动VTE风险降低(OR 0.52;95%CI 0.39-0.69),≤24小时启动未达统计学显著(OR 0.48;95%CI 0.14-1.60)。
  • 绝对风险降低:≤24小时分层为1.2%,≤48小时分层为2.1%,≤72小时分层为3.7%,反映各分层VTE事件率的差异。
  • 安全性:未见出血进展、神经外科干预或死亡率显著增加;≤48小时启动化学性VTE预防者死亡率显著更低(OR 0.74;95%CI 0.63-0.87)。
  • 偏倚风险:所有纳入研究偏倚风险为中至重度(采用非随机干预研究偏倚风险评估工具评估)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入研究为非随机干预研究,偏倚风险评估工具为非随机干预研究偏倚风险评估工具。
  • 所有纳入研究偏倚风险为中至重度。
  • 局限:研究存在异质性和偏倚风险,作者指出结果需谨慎解读,并强调需要高质量前瞻性研究。

对床旁实践的改变

  • 作者认为,重型TBI患者早期启动化学性VTE预防与VTE事件风险降低相关,≤48小时启动还伴死亡率获益,这些发现支持更早启动化学性VTE预防。
  • 作者指出,由于研究异质性和偏倚风险,结果应谨慎解读,并强调需要高质量前瞻性研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Patients with severe traumatic brain injury (TBI) are at high risk of venous thromboembolism (VTE). However, the optimal timing for initiating chemical VTE prophylaxis (cVTEp) remains controversial due to concerns for intracranial hemorrhage progression.

METHODS: Five databases were searched (inception to October 2024) for studies evaluating early versus late cVTEp initiation in severe TBI (defined as Glasgow Coma Scale score ≤ 8 or Abbreviated Injury Scale score ≥ 3). Data were extracted independently and pooled using random-effects models. Early versus late cVTEp initiation and stratified analyses (for cutoffs at ≤ 24, ≤ 48, and ≤ 72 h) were performed, and odds ratios (ORs) were calculated. Outcomes included VTE, hemorrhage progression, neurosurgical intervention, and in-hospital mortality. Absolute risk reduction (ARR) was calculated using control event rates and ORs. Risk of bias was assessed by the Risk of Bias in Non-Randomized Studies-of Interventions tool.

RESULTS: Twenty-one studies were included in the systematic review, with 14 (n = 24,401) included in the meta-analysis. Early compared to late cVTEp initiation was associated with lower odds of VTE (OR 0.47; 95% confidence interval [CI] 0.37-0.60), with consistent benefit at ≤ 48 h (OR 0.39; 95% CI 0.23-0.65) and at ≤ 72 h (OR 0.52; 95% CI 0.39-0.69) but not at ≤ 24 h (OR 0.48; 95% CI 0.14-1.60). The ARR of early vs. late initiation within each stratum was 1.2% for ≤ 24 h, 2.1% for ≤ 48 h, and 3.7% for ≤ 72 h, reflecting differences in the event rates for VTE in each stratum. No significant increase in hemorrhage progression, neurosurgical intervention, or mortality was observed. Notably, mortality was significantly lower for cVTEp initiated at ≤ 48 h (OR 0.74; 95% CI 0.63-0.87). All included studies had moderate to serious risk of bias.

CONCLUSIONS: Early cVTEp initiation in severe TBI was associated with lower odds of VTE events and a mortality benefit when initiated at ≤ 48 h. These findings support earlier cVTEp, but the results should be interpreted cautiously due to study heterogeneity and risk of bias, highlighting the need for high-quality prospective research.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Karmur BS, Mann JA, Leung AA, et al. Early Versus Late Initiation of Chemical Venous Thromboembolism Prophylaxis in Adult Patients with Severe Traumatic Brain Injury: A Systematic Review and Meta-analysis. Neurocrit Care. 2025. PMID: 41239163. doi:10.1007/s12028-025-02404-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。